Michigan's Chief Medical Executive Dr. Natasha Bagdasarian issued a standing recommendation directing the state's health care providers to follow respiratory virus immunization guidance from the American Medical Association when determining which vaccines patients should receive, according to the state health department.
The recommendation applies to COVID-19, influenza, and respiratory syncytial virus (RSV) vaccines for the 2026-2027 season. "Vaccines against COVID-19, RSV and influenza won't prevent every illness this winter – there are many other respiratory viruses circulating – but each vaccine provides important protection against viruses known to cause serious disease," Bagdasarian said.
The AMA's recommendations align with guidance from the American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, Vaccine Integrity Project and Infectious Diseases Society of America, the department said.
A standing recommendation on COVID-19 vaccines issued Sept. 19, 2025, remains in effect. Under that recommendation, any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is eligible to receive an age-appropriate dose.